Literature DB >> 6609358

Cloning and expression of cDNA encoding a bovine adrenal cytochrome P-450 specific for steroid 21-hydroxylation.

P C White, M I New, B Dupont.   

Abstract

We isolated a cDNA clone encoding a bovine adrenal cytochrome P-450 specific for steroid 21-hydroxylation (P-450C21). Serum from rabbits immunized with purified P-450C21 precipitated a single protein from the products of an in vitro translation reaction using bovine adrenal mRNA. This protein migrated with P-450C21 on NaDodSO4/polyacrylamide gel electrophoresis. After sucrose gradient sedimentation, mRNA encoding P-450C21 was found in the 19S fraction. This fraction was reverse transcribed into double-stranded cDNA and inserted into the Pst I site of pBR322 by the dC X dG tailing procedure. Escherichia coli cells transformed with recombinant plasmids were screened with an in situ immunoassay using anti-P-450C21 serum and 125I-labeled staphylococcal protein A. Two colonies consistently bound anti-P-450C21 serum. They were identified as carrying the same plasmid by restriction mapping. This plasmid, pC21a, contains an insert of 520 base pairs. It hybridizes with mRNA encoding P-450C21. The peptide encoded by the insert in pC21a is highly homologous to two peptides isolated from porcine P-450C21 and shows limited homology to the P-450 induced by phenobarbital in rat liver. This clone may be useful in studying the molecular genetics of human congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609358      PMCID: PMC345421          DOI: 10.1073/pnas.81.7.1986

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  Synthesis of a full length DNA complementary to thyroglobulin 33 S messenger RNA.

Authors:  G de Martynoff; E Pays; G Vassart
Journal:  Biochem Biophys Res Commun       Date:  1980-04-14       Impact factor: 3.575

3.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  Plasmid screening at high colony density.

Authors:  D Hanahan; M Meselson
Journal:  Gene       Date:  1980-06       Impact factor: 3.688

5.  Structure of cloned DNA complementary to rat prolactin messenger RNA.

Authors:  N E Cooke; D Coit; R I Weiner; J D Baxter; J A Martial
Journal:  J Biol Chem       Date:  1980-07-10       Impact factor: 5.157

6.  Mouse beta 2-microglobulin cDNA clones: a screening procedure for cDNA clones corresponding to rare mRNAs.

Authors:  J R Parnes; B Velan; A Felsenfeld; L Ramanathan; U Ferrini; E Appella; J G Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

7.  Construction and identification of a hybrid plasmid containing DNA sequence complementary to phenobarbital-inducible cytochrome P-450 messenger RNA from rat liver.

Authors:  Y Fujii-Kuriyama; T Taniguchi; Y Mizukami; M Sakai; Y Tashiro; M Muramatsu
Journal:  J Biochem       Date:  1981-06       Impact factor: 3.387

8.  Amino acid sequence of an analogous peptide from two forms of cytochrome P-450.

Authors:  J Ozols; F S Heinemann; E F Johnson
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

9.  An improved procedure for utilizing terminal transferase to add homopolymers to the 3' termini of DNA.

Authors:  G Deng; R Wu
Journal:  Nucleic Acids Res       Date:  1981-08-25       Impact factor: 16.971

10.  Isolation and characterization of a cloned DNA sequence associated with the murine Ah locus and a 3-methylcholanthrene-induced form of cytochrome P-450.

Authors:  M Negishi; D C Swan; L W Enquist; D W Nebert
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  30 in total

1.  Beta 2 agonists and asthma.

Authors:  J Rees
Journal:  BMJ       Date:  1991-05-18

2.  Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency.

Authors:  E Mornet; P Crété; F Kuttenn; M C Raux-Demay; J Boué; P C White; A Boué
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

3.  Prenatal DNA analysis in four embryos/fetuses at risk of 21-hydroxylase deficiency.

Authors:  T Matsumoto; T Kondoh; T Kamei; M Yoshimoto; Y Tsuji; K Suzumori; R Izumi; N Iwatani; N Niikawa
Journal:  Eur J Pediatr       Date:  1988-12       Impact factor: 3.183

Review 4.  The Gordon Wilson Lecture. Congenital adrenal hyperplasia.

Authors:  M I New
Journal:  Trans Am Clin Climatol Assoc       Date:  1991

5.  Incidence of cancer among ferrochromium and ferrosilicon workers: an extended observation period.

Authors:  S Langård; A Andersen; J Ravnestad
Journal:  Br J Ind Med       Date:  1990-01

6.  Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects.

Authors:  J A Bennett; A E Tattersfield
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

7.  Structure of a bovine gene for P-450c21 (steroid 21-hydroxylase) defines a novel cytochrome P-450 gene family.

Authors:  B C Chung; K J Matteson; W L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Isolation and sequence of a human cytochrome P-450 cDNA clone.

Authors:  I R Phillips; E A Shephard; A Ashworth; B R Rabin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

9.  Identification of a new HLA-B7-associated C21-hydroxylase deficiency gene by restriction enzyme length polymorphism.

Authors:  E Keller; A Andreas-Zietz; D Knorr; S Scholz; E D Albert
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

10.  Systemic effects of salbutamol and salmeterol in patients with asthma.

Authors:  J A Bennett; E T Smyth; I D Pavord; P J Wilding; A E Tattersfield
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.